Structure and Governance of the Medicines Transparency Alliance

  • 796 views
Uploaded on

Structure and governance of the Medicines Transparency Alliance (MeTA), May 2008

Structure and governance of the Medicines Transparency Alliance (MeTA), May 2008

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
796
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
9
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Garth Singleton MeTA Structures and Governance 04/06/09
  • 2. Introduction
    • Look at the various governance, advisory and management bodies involved in the international MeTA project and how they relate to each other.
    04/06/09
  • 3. Overview MeTA Management Board (MMB) International Advisory Group (IAG) International MeTA Secretariat DFID WHO WB Funding MeTA Country Forum and Secretariat 04/06/09
  • 4. MeTA Management Board
    • Members
      • DFID (Chair)
      • World Bank
      • World Health Organisation
      • Chair MeTA International Advisory Group
    • Terms of Reference
      • Project Management of DFID funded project
      • Coordination of World Bank, WHO and International Secretariat activities
    04/06/09
  • 5. MeTA International Advisory Group
    • Members
      • Representatives from 7 participating countries
      • Representatives from a broad spectrum of industry
      • Representatives from a broad spectrum of Civil Society
      • Representatives from the international community
      • Chaired by Sophia Tickell (SustainAbility)
    04/06/09
  • 6. MeTA International Advisory Group
    • Terms of Reference
      • Review findings emerging from participant countries.
      • Consider emerging trends in global pharmaceutical markets.
      • Assess developments and lessons emerging from the above and make recommendations for the future direction of MeTA.
      • Contribute to the agenda of international MeTA meetings
      • Make recommendations on research priorities (to ATM Research Network).
    04/06/09
  • 7. International MeTA Secretariat Secretariat Manager - Elizabeth Smith Executive Director Garth Singleton Country Programmes Technical Assistance Communications & Capacity Building – Andrew Chetley Technical Director – Wilbert Bannenberg Finance Administration Logistics Knowledge Management Capacity Development Private sector engagement 04/06/09
  • 8. International MeTA Secretariat
    • Terms of Reference
      • Coordinates, organises, promotes & supports implementation of MeTA at Global and National levels.
      • Channels Technical and Financial support to MeTA pilot countries.
      • Maintains contact with international and national stakeholders.
      • Capacity strengthening.
      • Organises global & regional meetings.
      • Supports MeTA governance structures.
    04/06/09
  • 9. Participant Country Organisation Country MeTA Secretariat International MeTA Secretariat MeTA Country Forum MeTA International Advisory Group 04/06/09
  • 10. MeTA Country Stakeholder Forum
    • Multistakeholder Forum comprising:
      • Government (MOH, Drug Regulatory Authority, National Procurement Agency, etc.).
      • Private Sector (Drug manufacturers, importers, wholesalers, retailers)
      • Civil Society Groups (representing patients, consumers, good governance and transparency, professional bodies etc.).
    04/06/09
  • 11. MeTA Country Stakeholder Forum
    • Role:
      • Forum for discussion between stakeholders
      • Agree and monitor an annual workplan of activities that further the national aims of MeTA
      • Workplan funded from International Secretariat, WHO and World Bank as well as, it is hoped, other sources.
    04/06/09
  • 12. MeTA Country Secretariat
    • Preferably attached to an existing country Institution
    • Functions
      • To coordinate and support the implementation of the annual work plan.
      • To present and disseminate findings for discussion within the Country Stakeholder Forum.
      • Financial management and reporting of MeTA funds
      • Maintain links with International Secretariat.
    04/06/09
  • 13. Thank you!
    • Garth Singleton
    • [email_address]
    • +44 (0) 1273 486861
    • International Secretariat, info@metasecretariat.org
    • MeTA: www.MedicinesTransparency.org
    • DFID: www.dfid.gov.uk
    06/04/09